Probiotics are live micro-organisms, when administered in adequate amount confer a health benefit on the host”, is the standard definition provided by the Food and Agriculture Association (FAO) of the United Nations. These friendly and live bacteria, when administered to and/or consumed by humans in the non-food form, are referred to as ‘probiotic supplements’, which are generally available either in the form of tablets, capsules, powder, liquid, chewables, and others. As an impact of busy, modern lifestyle, the consumption of healthy food among humans has been limited, and at times, individuals disturb the delicate balance of the body’s intestinal flora, which can cause occasional gastrointestinal discomfort, and infection in other body parts.
Therefore, a healthy balance of intestinal flora and infection control can be supported through the consumption of food or food supplement products that contain friendly live bacteria cultures, commonly referred to as ‘probiotics’.
Request For Report Brochure For Latest Industry Insights @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=386
Key Taxonomy Insights
- By form, the dry segment is likely to be the most attractive segment in the forecast period owing to the availability of larger product variants coupled increasing product offerings in powder/granule format.
- On the basis of packaging type, the containers segment is estimated to account for a significant revenue share of 24.7% in 2018 and is expected to register significant growth rate during the forecast period. However, the bottle segment is expected to register a higher CAGR value of 8.7%.
- Furthermore, on the basis of distribution channel, relatively higher internet penetration across the globe has led to the emergence of e-Commerce as an easily accessible and convenient sales channel for a range of products.
- In terms of value, North America and Europe are likely to account for approximately a share of 79.9% by the end of 2026. Also, North America is expected to dominate the market through 2026 in terms of demand, followed by Europe and Asia Pacific.
Obtain Report Details @ https://www.transparencymarketresearch.com/pressrelease/probiotics-market.htm
Key Drivers & Restraints Impacting the Market Performance through 2026
Consumption of antibiotics per capita is increasing on the backdrop of the increase in healthcare expenditure and out of pocket pharmaceutical spending. Low and middle income countries are growing in terms of per capita disposable income, and this factor is boosting antibiotic consumption in these countries. Furthermore, favorable policies to push antibiotics in these countries have amplified the usage of antibiotics in some of these countries. Excessive usage of antibiotics by an individual results in imbalance of microbiota, and also lowers the bacterial diversity as well as overall bacterial count in the gut.